Compare NVNO & BON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVNO | BON |
|---|---|---|
| Founded | 1987 | 2006 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3M | 14.6M |
| IPO Year | N/A | 2021 |
| Metric | NVNO | BON |
|---|---|---|
| Price | $0.36 | $1.72 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 417.4K | 40.8K |
| Earning Date | 02-27-2026 | 01-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.46 |
| Revenue | N/A | ★ $21,610,848.00 |
| Revenue This Year | N/A | $223.38 |
| Revenue Next Year | N/A | $18.82 |
| P/E Ratio | ★ N/A | $0.67 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.30 | $1.14 |
| 52 Week High | $5.62 | $73.75 |
| Indicator | NVNO | BON |
|---|---|---|
| Relative Strength Index (RSI) | 44.53 | 49.37 |
| Support Level | $0.35 | $1.45 |
| Resistance Level | $0.39 | $1.73 |
| Average True Range (ATR) | 0.03 | 0.12 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 52.36 | 73.52 |
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. Xi'an App-Chem is devoted to providing high quality and competitive prices and a stable supply of products and services for the functional food, personal care, natural medicine and other industries. It provides these products and services for third party customers, as well as for its own proprietary brands. The company has its geographic presence in PRC and in Overseas. The company derives maximum revenue from Bioactive food ingredients.